Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)

Direct Payment

$70,000.00

Does Treatment with Continuous Positive Airway Pressure Decrease Symptom Burden and Improve Functional Outcomes in Stoke Patients with Obstructive Sleep Apnea? A Randomized Controlled Trial.

EF 2010-11

Résumé
Over 300,000 Canadian are living with the long-term, negative effects of stroke. In addition to cognitive difficulties, stroke patients experience serious negative psychological symptoms such as fatigue and depression. Side effects often persist long after the initial stroke and a substantial number of patients list symptom such as fatigue as their worse long-term stroke associated problem. Additionally, symptoms such as fatigue are linked to worse functional impairment and reduced recovery of independent daily living functions. Multiple factors likely contribute to the symptom burden experienced by stroke patients, one of which is underlying obstructive sleep apnea (OSA). OSA is a disorder in which patients have periods of disrupted breathing during sleep. The side effects of OSA include fatigue, depression, and cognitive impairments, the same symptoms observed in many stroke survivors. Given that greater than 60% of stroke patients have comorbid OSA, a natural question is whether the common symptoms between the two disorders can be improved by properly treating OSA. The most common treatment for OSA is continuous positive airway pressure (CPAP). Research shows that patients who are successfully treated with CPAP report dramatic improvements in fatigue and domains of cognitive functioning. The primary aim of the proposed study is to examine if treatment with therapeutic CPAP (versus placebo) will reduce the symptom burden of fatigue, depression and cognitive impairment and improve functional outcomes in stroke patients with comorbid OSA. Given that CPAP has a heavy response burden, our study will help establish whether treatment of OSA is able to counteract the symptom burden that stroke patient's experience, even in the face of the continuing morbidity from the stroke itself.
Programme
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Bénéficiaire
Emplacement
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
229510
Name
Tomfohr-Madsen Lianne M
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Does Treatment with Continuous Positive Airway Pressure Decrease Symptom Burden and Improve Functional Outcomes in Stoke Patients with Obstructive Sleep Apnea? A Randomized Controlled Trial.
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Cognitive Impairment; Continuous Positive Airway Pressure; Depression; Fatigue; Functional Outcomes; Obstructive Sleep Apnea; Randomized Clinical Trial; Stroke
Abstract
Over 300,000 Canadian are living with the long-term, negative effects of stroke. In addition to cognitive difficulties, stroke patients experience serious negative psychological symptoms such as fatigue and depression. Side effects often persist long after the initial stroke and a substantial number of patients list symptom such as fatigue as their worse long-term stroke associated problem. Additionally, symptoms such as fatigue are linked to worse functional impairment and reduced recovery of independent daily living functions. Multiple factors likely contribute to the symptom burden experienced by stroke patients, one of which is underlying obstructive sleep apnea (OSA). OSA is a disorder in which patients have periods of disrupted breathing during sleep. The side effects of OSA include fatigue, depression, and cognitive impairments, the same symptoms observed in many stroke survivors. Given that greater than 60% of stroke patients have comorbid OSA, a natural question is whether the common symptoms between the two disorders can be improved by properly treating OSA. The most common treatment for OSA is continuous positive airway pressure (CPAP). Research shows that patients who are successfully treated with CPAP report dramatic improvements in fatigue and domains of cognitive functioning. The primary aim of the proposed study is to examine if treatment with therapeutic CPAP (versus placebo) will reduce the symptom burden of fatigue, depression and cognitive impairment and improve functional outcomes in stroke patients with comorbid OSA. Given that CPAP has a heavy response burden, our study will help establish whether treatment of OSA is able to counteract the symptom burden that stroke patient's experience, even in the face of the continuing morbidity from the stroke itself.
Competitiondate
201010
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Tomfohr-Madsen, Lianne M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~